DJ Corbus Pharmaceuticals Holdings Inc. Stock Underperforms Tuesday When Compared To Competitors
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Corbus Pharmaceuticals Holdings Inc. $(CRBP)$ slipped 5.18% to $42.69 Tuesday, on what proved to be an all-around mixed trading session for the stock market, with the NASDAQ Composite Index rising 0.59% to 17,019.88 and the Dow Jones Industrial Average falling 0.55% to 38,852.86.
Corbus Pharmaceuticals Holdings Inc. closed $7.73 below its 52-week high ($50.42), which the company reached on May 21st.
The stock underperformed when compared to some of its competitors Tuesday, as Vanda Pharmaceuticals Inc. $(VNDA)$ fell 4.78% to $4.98, Fortress Biotech Inc. (FBIO) fell 4.81% to $1.78, and Viking Therapeutics Inc. $(VKTX)$ rose 4.16% to $65.36.
Trading volume (140,510) remained 86,920 below its 50-day average volume of 227,430.
Data source: Dow Jones Market Data, FactSet. Data compiled May 28, 2024.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
May 28, 2024 17:27 ET (21:27 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.
Comments